malignant hematopathy恶性血液病
hematopathy patients血液病
hematonosis hematopathy血液病
hematopathy sickroom血液病房
department of hematopathy血液病科
patients with benign hematopathy良性血液病
inpatients with hematopathy血液病病人
Children with hematopathy血液病患儿
difficult and complicated hematopathy疑难血液病
Conclusion Linezolid has high safety and excellent clinical efficacy in the treatment of gram-positive bacteria infection in malignant hematopathy patients.
结论利奈唑胺用于恶性血液病患者革兰阳性菌感染的治疗有较好临床疗效,且副反应小,安全性好。
参考来源 - 利奈唑胺治疗恶性血液病并革兰阳性菌感染18例临床研究